We are overjoyed to be able to bring you the news that the FDA has approved risdiplam for the treatment of types 1, 2 and 3 with no age restrictions.
On Friday evening TreatSMA hosted a webinar with Michelle Woods who is a SENDCo at a primary school in Kent. She has been a primary school teacher for 20 years and a SENDCo for 6 years. Michelle currently works in a primary school with a Special Resourced Provision (SRP) for children with physical disabilities and…
Another amazing session with Marion, this episode focusing on pain.
On Friday evening TreatSMA hosted a webinar with Michelle Woods who is a SENDCo at a primary school in Kent. She has been a primary school teacher for 20 years and a SENDCo for 6 years. Michelle currently works in a primary school with a Special Resourced Provision (SRP) for children with physical disabilities and…
Another amazing session with Marion, this episode focusing on pain.
This year, TreatSMA wanted to present a range of topics for the community, but they were also particularly keen to remember and acknowledge those that fought/fight and got the community where it is today, not just in regards to SMA but disability itself. The ongoing battle for equality and disability rights fought by so many should…
In this session Marion focused on those who have more physical strength and those with type 3. As ever lots of questions and lots of discussion, please do take a look.
In this session Marion focused on those who have more physical strength and those with type 3. As ever lots of questions and lots of discussion, please do take a look.